China’s COVID-19 vaccine trials suspended in Brazil after ‘severe incident’
Brazil's health regulator Anvisa has suspended clinical trials of China's Sinovac COVID-19 vaccine in the country following a "severe incident".On Monday, Anvisa said it had "ruled to interrupt the clinical trial of the CoronaVac vaccine after a serious adverse incident". It did not reveal what had happened, nor where it had taken place.It also did not give an indication of how long the suspension of the large late-stage trial of China's Sinovac coronavirus vaccine might last in Brazil.President Jair Bolsonaro hailed the suspension as a “victory” and said that their government would buy whatever coronavirus vaccine is certified by Anvisa.Writing on Facebook, the president said the halt of the CoronaVac trial was "another victory for Jair Bolsonaro".The vaccine, developed by Chinese firm Si